엠벡타 (EMBC) 주가

엠벡타(EMBC)는 NAS에 상장된 Healthcare · Medical Instruments & Supplies 기업입니다. 현재가 $5.29 (+1.93%), 시가총액 $186.29M, PER 1.66, 52주 범위 $3.12 ~ $15.31.

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

핵심 지표

• 현재가: $5.29 (+1.93%)
• 시가총액: $186.29M
• PER (주가수익비율): 1.66
• 52주 최저~최고: $3.12 ~ $15.31
• 섹터: Healthcare
• 산업: Medical Instruments & Supplies
• 거래소: NAS

엠벡타의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

엠벡타 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 보유 (3.2 / 5)

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.61
• 순이익률: 10.73%
• 영업이익률: 19.34%
• 배당수익률: 19.11%

자주 묻는 질문